4//SEC Filing
JOHNSON JOHN 4
Accession 0001410781-25-000006
CIK 0001867096other
Filed
Dec 18, 7:00 PM ET
Accepted
Dec 19, 5:17 PM ET
Size
5.0 KB
Accession
0001410781-25-000006
Insider Transaction Report
Form 4
Johnson John H
Director
Transactions
- Sale
Common Stock
2025-12-19$7.22/sh−135,400$977,019→ 698,083 total
Footnotes (1)
- [F1]The price reported is a weighted average price. These shares were sold in multiple transactions at prices ranging from $7.200 to $7.275, inclusive. The reporting person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range.
Documents
Issuer
Xeris Biopharma Holdings, Inc.
CIK 0001867096
Entity typeother
Related Parties
1- filerCIK 0001410781
Filing Metadata
- Form type
- 4
- Filed
- Dec 18, 7:00 PM ET
- Accepted
- Dec 19, 5:17 PM ET
- Size
- 5.0 KB